Compare Gap Inc (GAP) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gap Inc vs Tempus AI — how do they compare? Gap Inc trades at $23.21 (market cap $8.21B), while Tempus AI trades at $71 (market cap $12.58B). The key difference: Tempus AI is the larger of the two by market cap, and Gap Inc pays a 3% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gap Inc for 37 Days and Tempus AI for 23 Days on average.
| GAP | TEM | |
|---|---|---|
Market Cap | $8.21B | $12.58B |
Volume | 5,192,917 | 7,444,569 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $29.13 | $99.28 |
52-Week Low | $18.35 | $41.55 |
Typical Hold Time | 37 Days | 23 Days |
Enterprise Value | $11.44B | $13.21B |
Dividend Yield | 3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gap trades at $23.23, down 1.61% on the day, with strong technical momentum as moving averages signal bullish sentiment. The company demonstrates robust fundamentals with a P/E of 7.04, net income margin of 8.14%, and consistent earnings beats in recent quarters. Recent developments include strategic brand partnerships in music and sports, positioning Gap for cultural relevance growth.
The outlook remains positive with analyst consensus target of $25.67 offering 10.5% upside potential. Key opportunities include margin expansion and brand momentum, while risks involve Old Navy's sales decline and competitive retail pressures. Institutional activity shows mixed signals with both position increases and reductions in Q2 2026.
Tempus AI (TEM) trades at $71.46, up 1.66% with a bullish technical signal despite negative profitability metrics. The stock shows strong analyst support with 9 buy ratings and a $72.60 consensus target. Recent FDA clearance for ECG-MR AI product and 13 ESMO Congress presentations highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist at -$254M.
Outlook remains cautiously optimistic given strong institutional backing and AI healthcare growth potential, but profitability challenges and insider selling present near-term risks. The stock's valuation appears stretched with P/S of 8.61 and P/B of 28.27, requiring sustained revenue acceleration to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gap Inc
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
Read more on GAP →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
